CD47 and leukemia: Given the rapid emergence of new targeted anti-leukemia therapies, such studies should be further expanded to CD47 macrophage checkpoint inhibitors (131) and the growing number of anti-leukemic small molecules with potential implications for antifungal immunity (132).